Chapel Hill, NORTH%20CAROLINA3 Active Studies

Multiple Myeloma Clinical Trials in Chapel Hill, NORTH%20CAROLINA

Find 3 actively recruiting multiple myeloma clinical trials in Chapel Hill, NORTH%20CAROLINA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
647
Enrolling

Recruiting Multiple Myeloma Studies in Chapel Hill

About Multiple Myeloma Clinical Trials in Chapel Hill

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 3 multiple myeloma clinical trials recruiting participants in Chapel Hill, NORTH%20CAROLINA. These studies are seeking a combined 647 participants. Research is being sponsored by AbbVie, University of Texas Southwestern Medical Center, UNC Lineberger Comprehensive Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Chapel Hill — FAQ

Are there multiple myeloma clinical trials in Chapel Hill?

Yes, there are 3 multiple myeloma clinical trials currently recruiting in Chapel Hill, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chapel Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.

Are clinical trials in Chapel Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 3 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated March 2, 2026 from ClinicalTrials.gov